Skip to Main Content

2,486

Views

0

CrossRef citations to date

0

Altmetric

Original Research

23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function

Jill Fenauxa Immuno-Oncology, 23andMe, South San Francisco, CA, USAView further author information

,

Xin Fangb Computational Biology, 23andMe, South San Francisco, CA, USAView further author information

,

Yao-ming Huangc Antibody and Protein Engineering, 23andMe, South San Francisco, CA, USAView further author information

,

Cristina Meleroc Antibody and Protein Engineering, 23andMe, South San Francisco, CA, USAView further author information

,

Caroline Bonnansd In Vivo Pharmacology, 23andMe, South San Francisco, CA, USAView further author information

,

Earth Light Lowed In Vivo Pharmacology, 23andMe, South San Francisco, CA, USAView further author information

,

Tiziana Palumbod In Vivo Pharmacology, 23andMe, South San Francisco, CA, USAView further author information

,

Cecilia Laya Immuno-Oncology, 23andMe, South San Francisco, CA, USAView further author information

,

Zuoan Yia Immuno-Oncology, 23andMe, South San Francisco, CA, USAView further author information

,

Aileen Zhoua Immuno-Oncology, 23andMe, South San Francisco, CA, USAView further author information

,

Mauro Poggioa Immuno-Oncology, 23andMe, South San Francisco, CA, USAView further author information

,

Wei-Jen Chungb Computational Biology, 23andMe, South San Francisco, CA, USAView further author information

,

Sophia R. Majeede Clinical Science, 23andMe, South San Francisco, CA, USAView further author information

,

Dylan Glattf Clinical Pharmacology, 23andMe, South San Francisco, CA, USAView further author information

,

Alice Chena Immuno-Oncology, 23andMe, South San Francisco, CA, USAView further author information

,

Maike Schmidtg Biomarker Translation, 23andMe, South San Francisco, CA, USAView further author information

&

Clarissa C. Leea Immuno-Oncology, 23andMe, South San Francisco, CA, USACorrespondence[email protected]
View further author information